loading
Precedente Chiudi:
$1.17
Aprire:
$1.15
Volume 24 ore:
45,897
Relative Volume:
0.91
Capitalizzazione di mercato:
$19.38M
Reddito:
-
Utile/perdita netta:
$-52.53M
Rapporto P/E:
-0.2947
EPS:
-3.97
Flusso di cassa netto:
$-39.93M
1 W Prestazione:
-7.14%
1M Prestazione:
-16.43%
6M Prestazione:
-19.86%
1 anno Prestazione:
-43.20%
Intervallo 1D:
Value
$1.14
$1.17
Intervallo di 1 settimana:
Value
$1.14
$1.2898
Portata 52W:
Value
$1.105
$2.17

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
Nome
Unity Biotechnology Inc
Name
Telefono
(650) 416-1192
Name
Indirizzo
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
Dipendente
19
Name
Cinguettio
@unitybiotech
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
UBX's Discussions on Twitter

Confronta UBX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
UBX 1.17 19.38M 0 -52.53M -39.93M -3.97
VRTX 449.44 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.00 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.25 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.03 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.90 24.89B 3.30B -501.07M 1.03B 11.54

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-01-04 Aggiornamento ROTH Capital Neutral → Buy
2021-11-10 Aggiornamento Mizuho Neutral → Buy
2021-06-28 Aggiornamento Citigroup Sell → Buy
2021-06-07 Iniziato H.C. Wainwright Buy
2021-02-16 Downgrade Citigroup Neutral → Sell
2020-08-18 Downgrade Citigroup Buy → Neutral
2020-08-18 Downgrade Mizuho Buy → Neutral
2020-08-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-08-17 Downgrade ROTH Capital Buy → Neutral
2020-07-28 Iniziato ROTH Capital Buy
2019-12-12 Iniziato Cantor Fitzgerald Overweight
2019-03-07 Iniziato Cantor Fitzgerald Overweight
2018-09-07 Iniziato Mizuho Buy
2018-05-29 Iniziato Citigroup Buy
2018-05-29 Iniziato Goldman Neutral
2018-05-29 Iniziato Morgan Stanley Overweight
Mostra tutto

Unity Biotechnology Inc Borsa (UBX) Ultime notizie

pulisher
Nov 19, 2024

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace

Nov 19, 2024
pulisher
Nov 15, 2024

Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com

Nov 15, 2024
pulisher
Nov 07, 2024

Unity Biotechnology's CFO sells shares worth $175 - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Unity Biotechnology's chief legal officer sells shares worth $192 - Investing.com

Nov 07, 2024
pulisher
Nov 06, 2024

Unity Biotechnology's CFO sells shares worth $175 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology's chief legal officer sells shares worth $192 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology stock hits 52-week low at $1.15 - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology CEO Anirvan Ghosh sells $557 in stock By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 05, 2024

Unity Biotechnology stock hits 52-week low at $1.15 By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth? - Simply Wall St

Nov 05, 2024
pulisher
Nov 04, 2024

Unity Biotechnology Focuses on Promising DME Treatment - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewswire

Nov 04, 2024
pulisher
Oct 22, 2024

Age-related Macular Degeneration Market Size is Set for Rapid - openPR

Oct 22, 2024
pulisher
Oct 16, 2024

Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 16, 2024
pulisher
Oct 16, 2024

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals - Yahoo Finance UK

Oct 16, 2024
pulisher
Oct 11, 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial - Ophthalmology Times

Oct 11, 2024
pulisher
Oct 09, 2024

Empery Asset Management, LP Acquires Shares in Volcon Inc - Yahoo Finance UK

Oct 09, 2024
pulisher
Oct 09, 2024

Empery Asset Management's Strategic Acquisition in Elevation Oncology - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Empery Asset Management's Strategic Reduction in Sharps Technology Inc - Yahoo Finance

Oct 09, 2024
pulisher
Oct 03, 2024

To Reverse Aging’s Clock, Adjust the Cell’s Machinery - Genetic Engineering & Biotechnology News

Oct 03, 2024
pulisher
Sep 24, 2024

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - GlobeNewswire

Sep 24, 2024
pulisher
Sep 24, 2024

Unity Biotechnology (FRA:9U90) Cash Ratio : 3.85 (As of Jun. 2024) - GuruFocus.com

Sep 24, 2024
pulisher
Sep 23, 2024

Jefferies Financial Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $432.00 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Sep 23, 2024
pulisher
Sep 22, 2024

Epoch Investment Partners Inc. Increases Stake in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Symmetry Investments LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

American Century Companies Inc. Has $13.14 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Pacer Advisors Inc. Grows Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Meiji Yasuda Asset Management Co Ltd. Buys 33 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Longevity and Anti-Senescence Therapy Market Share, Size, Growth, and Forecast to 2031 - InsightAce Analytic

Sep 20, 2024
pulisher
Sep 19, 2024

Inspire Investing LLC Acquires 2,936 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Uniti Group Inc [UNIT] stock was sold by Mudry Ronald J. at the price of US$0.11 million - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

1,054 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Choreo LLC - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Quest Partners LLC Has $89,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Liquidia Corp faces renewed legal challenge from United Therapeutics By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Meeder Advisory Services Inc. Invests $36,000 in Uniti Group Inc. (NASDAQ:UNIT) - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Unity Software Inc. (NYSE:U) Shares Bought by Daiwa Securities Group Inc. - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Commonwealth Equity Services LLC Has $1.16 Million Position in Unity Software Inc. (NYSE:U) - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Court rules against United Therapeutics in Liquidia case - Investing.com India

Sep 16, 2024
pulisher
Sep 15, 2024

Royal London Asset Management Ltd. Boosts Stake in Unity Software Inc. (NYSE:U) - Defense World

Sep 15, 2024
pulisher
Sep 14, 2024

694 Shares in United Therapeutics Co. (NASDAQ:UTHR) Purchased by Caprock Group LLC - Defense World

Sep 14, 2024
pulisher
Sep 04, 2024

Anti-Senescence Therapy Market is Likely to Upsurge at USD 25.16 Bn- Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa – Daily News Mirror - Daily News Mirror

Sep 04, 2024
pulisher
Aug 31, 2024

The Top 8 Things to Know About Anti-Aging Research Right Now - upworthyscience.com

Aug 31, 2024
pulisher
Aug 20, 2024

UBX (Unity Biotechnology) Debt-to-Equity : 1.10 (As of Jun. 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

Billionaires are spending big so they — and maybe you — can live forever - MarketWatch

Aug 19, 2024
pulisher
Aug 18, 2024

Unity Biotechnology (FRA:9U90) Net-Net Working Capital : €0.01 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

UBX (Unity Biotechnology) EV-to-Revenue : (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

UBX (Unity Biotechnology) EPS (Basic) : $-1.74 (TTM As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

UBX (Unity Biotechnology) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024

Unity Biotechnology Inc Azioni (UBX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):